BRÈVE

sur B.R.A.I.N. Biotechnology Research And Information Network AG (isin : DE0005203947)

BRAIN Biotech and AMSilk Announce Breakthrough in Protein Engineering for Sustainable Textiles

BRAIN Biotech AG, a leading provider of industry biologization solutions, together with AMSilk GmbH, a pioneer in advanced spider silk-based materials, have successfully completed the initial phase of their development collaboration. This partnership culminated in the enhancement of a natural structural protein and the subsequent registration of a PCT patent for the refined process. The collaboration aims to revolutionize the performance materials market by optimizing protein-based fibers for diverse, high-performance applications in textiles, emphasizing both economic and environmental sustainability.

The collaboration leverages BRAIN Biotech's proficiency in protein engineering and bioinformatics for boundary-pushing protein design, achieving significant advancements in the textile industry. AMSilk's spider silk-based proteins, noted for their exceptional strength and flexibility, offer a biodegradable, recyclable alternative to conventional materials, drastically reducing carbon footprint and microplastic presence.

The strategic R&D partnership builds on BRAIN Biotech’s successful history in protein engineering, utilizing advanced bioinformatics and AI predictions. This amalgamation of expertise and technology facilitates the creation of specifically tailored materials that meet stringent market demands while aligning with sustainability goals. The venture not only promises a leap towards eco-friendly textile solutions but also sets new performance benchmarks within the apparel industry.

Dr. Alexander Pelzer of BRAIN Biotech and Gudrun Vogtentanz of AMSilk both highlighted the significance of this cooperation, underscoring the potential for their combined efforts to instigate a long-term transformation in the performance materials sphere, moving away from reliance on fossil-based textiles.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de B.R.A.I.N. Biotechnology Research And Information Network AG